MedWatch

Jesper Høiland gibes at Eli Lilly CEO: “He is pathetic”

CEO in Radius Health, Danish Jesper Høiland, enjoys competing against Eli Lilly, his old rival from his time in Novo Nordisk. But he does not care much for the rivaling CEO’s view on the rising prices on medicine in the US. 

Foto: /Ritzau Scanpix/Niels Ahlmann Olesen/

Last summer, Danish Jesper Høiland took position as CEO in the US-based biotech company Radius Health and his most important task is currently to ensure a successful US launch of the company’s main asset Tymlos (abaloparatide) against osteoporosis.

It means that he is to compete against major US company Eli Lilly that for more than 15 years has marketed a similar product and had a monopoly on the market segment.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier